Immune Pharmaceuticals initiates Phase II trials of bertilimumab in ulcerative colitis and bullous pemphigoid
26 June 2015 | By Victoria White
Immune Pharmaceuticals has initiated a Phase II trial of bertilimumab in ulcerative colitis and will initiate a Phase II bullous pemphigoid trial in July...